Article
Fintech & Payments AI & Machine Learning PayPal

PayPal keeps deal door open as earnings top forecasts

PayPal beat second-quarter estimates and raised its full-year outlook even as chief executive Enrique Lores said the company remains "open and objective" to acquisition offers amid reports of Stripe interest.

by tickstock newsroom
The image features a close-up view of a smartphone screen displaying the PayPal app icon. The logo is prominently featured against a blurred background, emphasizing digital finance and payment technology. — Credit: Photo by Brett Jordan on Unsplash c Photo by Brett Jordan on Unsplash

PayPal (NASDAQ:PYPL) reported second-quarter revenue of $8.68 billion, up 5% year over year, as investors pressed management for clarity on takeover speculation involving Stripe.

Total payment volume reached $487 billion for the quarter ended June 30, up 9% from the same period a year earlier, though net income fell to $1.104 billion from $1.261 billion.

"We don't comment on market speculation," Lores said on Tuesday's earnings call.

"We remain open and objective. If we see levers that will create superior value to shareholders, we will of course carefully consider them."

The remarks follow reports that PayPal's board determined an earlier $53 billion offer from Stripe fell short of the company's valuation expectations.

Lores, who took over as PayPal's chief executive in February following a leadership shakeup, has spent the months since pushing a turnaround built around AI-driven commerce partnerships and cost cuts.

PayPal raised its outlook for the remainder of 2026 and lifted its profitability guidance, saying the turnaround is progressing. BofA noted that near-term stock performance is likely to hinge more on deal developments than on operating results.

News Intelligence what this means for the company

PayPal beat Q2 revenue expectations ($8.68 billion, up 5% YoY) and raised full-year guidance, but the earnings call was dominated by acquisition chatter: CEO Enrique Lores signaled openness to takeover offers after reports that Stripe's $53 billion bid fell short of the board's valuation floor. Net income actually declined year over year despite revenue growth, and BofA flagged that near-term stock moves will likely track deal developments rather than operating performance.

Knock-on
  • If a deal materializes at a price above $53 billion, it would represent a significant premium to Stripe's reported offer and validate the board's rejection; if no buyer emerges at that level, the stock may face pressure as the turnaround narrative alone has not yet arrested the net income decline.
  • The company's stablecoin expansion (PYUSD now in 70 markets) and AI commerce partnerships (Cymbio acquisition, Perplexity integration) are core to Lores's turnaround thesis, but their revenue contribution remains opaque—deal uncertainty may obscure visibility into whether these initiatives are moving the needle operationally.
Investment case

PayPal's operational turnaround is real (raised guidance, payment volume up 9%), but the net income decline and CEO's explicit openness to sale create a binary outcome: either a transformative deal emerges or investors must trust that cost cuts and AI-driven commerce will eventually restore profitability. The $53 billion floor suggests the board believes intrinsic value is materially higher, but that belief is unproven absent a buyer.

Insights assembled by AI. Editor-reviewed and grounded in tickstock’s coverage and proprietary knowledge graph.

Content is for informational purposes only, not financial advice.

by tickstock newsroom

Related Stories

The image features silhouetted figures in long cloaks walking through a misty environment adorned with cascading digital code. The scene evokes a blend of mystery and technology, with soft glowing colors in the background enhancing its futuristic atmosphere.

Tech Today: Defence Holdings, Tern, Potentially AI, Dotdigital

Small-cap tech and healthcare names delivered a mixed session of clinical validation, strategic tie-ups and confirmed guidance. The standout news came from peer-reviewed publication of pediatric trial results underpinning an iron-deficiency drug's expansion into younger patients, while AI platform P